Bottom line
SHPCX vs BBH: the short answer
SHPCX (Health & Biotechnology Portfolio) and BBH (VanEck Biotech ETF) are both mutual funds.
BBH is cheaper at 0.35% vs 3.6% — a difference of $325 a year per $10,000 invested.
Over five years, SHPCX returned +3.7% a year vs +2.7% for BBH (reporting dates differ).
Updated Nov 19, 2026
SHPCX vs BBH side by side
| SHPCX | BBH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Saratoga Advantage | VanEck |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 3.6% | 0.35% |
| Annual cost per $10k | $360 | $35 |
| 10-yr cost on $10k (prospectus) | $3,862 | $443 |
| Max front load | 0% | None |
| 12b-1 fee | — | — |
| 1-yr return | −1.3% | +21.2% |
| 5-yr return (annualized) | +3.7% | +2.7% |
| 10-yr return (annualized) | +4.1% | +4.5% |
| Best quarter | +15.0% | +27.6% |
| Worst quarter | −13.0% | −18.2% |
| Net assets (fund) | $10.5M | $395.6M |
| Number of holdings | 29 | 25 |
| Portfolio turnover | 22% | 19% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SHPCX | BBH | Difference |
|---|---|---|---|
| 2024 | −0.3% | −4.4% | +4.1% |
| 2023 | −0.9% | +3.9% | −4.8% |
| 2022 | +1.4% | −15.1% | +16.5% |
| 2021 | +16.0% | +11.8% | +4.2% |
| 2020 | +3.0% | +22.1% | −19.0% |
| 2019 | +15.4% | +25.8% | −10.3% |
| 2018 | −6.0% | −10.2% | +4.2% |
| 2017 | +11.3% | +16.6% | −5.4% |
| 2016 | −2.5% | −15.0% | +12.5% |
Source: Fund prospectus bar charts
Holdings overlap
6 of SHPCX's top 25 holdings also appear in BBH's top 25.
| Holding | SHPCX | BBH |
|---|---|---|
| United Therapeutics Corp | 6.17% | 2.83% |
| Amgen Inc | 5.04% | 15.25% |
| Gilead Sciences Inc | 3.94% | 12.79% |
| Regeneron Pharmaceuticals Inc | 3.93% | 6.21% |
| Vertex Pharmaceuticals Inc | 3.36% | 9.10% |
| Incyte Corp | 2.89% | 2.49% |
Source: SEC Form N-PORT
SHPCX top 10
- Cardinal Health Inc — 6.44%
- Jazz Pharmaceuticals Plc — 6.19%
- United Therapeutics Corp — 6.17%
- Amgen Inc — 5.04%
- Mckesson Corp — 4.90%
- Lantheus Holdings Inc — 4.64%
- Exelixis Inc — 4.55%
- Novartis Ag — 4.50%
- Cencora Inc — 4.33%
- Gilead Sciences Inc — 3.94%
BBH top 10
- Amgen Inc — 15.25%
- Gilead Sciences Inc — 12.79%
- Vertex Pharmaceuticals Inc — 9.10%
- Regeneron Pharmaceuticals Inc — 6.21%
- Revolution Medicines Inc — 5.27%
- Argenx SE — 4.97%
- Natera Inc — 4.92%
- IQVIA Holdings Inc — 4.31%
- Alnylam Pharmaceuticals Inc — 3.83%
- Biogen Inc — 3.63%
FAQ
What is the difference between SHPCX and BBH?
Which is cheaper, SHPCX or BBH?
Should I own both SHPCX and BBH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.